Table 4 Time to until detection of active CMV infection by pp65 antigenemia, nested-PCR and real-time PCR
N° Patients | Median (days after HSCT) | Range | |
|---|---|---|---|
Patients with active CMV infection | 27 (90%) | 33 | 0 - 119 |
Positive pp65 antigenemia (%) | 13 (43.3%) | 40 | 29 - 152 |
Positive nested-PCR (%) | 21 (70%) | 33 | 0 - 126 |
Positive real-time PCR (%) | 23 (76.7%) | 40 | 0 - 119 |